Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.

  • Colorado moves to curb opioid utilization

    | May 24, 2018
    Tag Icon
    Workers' Compensation, Pain Management, PDMPs, Opioids
    Recently, Colorado’s Governor signed into law Senate Bill 22, which enacts opioid prescribing restrictions as well as enhanced PDMP reviewing/reporting requirements. The bill also requires that the PDMP program develop and provide prescribers of opioids a “health care provider report card” related to their prescribing patterns.

  • FDA approves first-in-class medication to prevent migraine

    • Optum Workers' Comp
    | May 22, 2018
    Tag Icon
    Pain Management, FDA, Migraine
    The U.S. Food and Drug Administration (FDA) approved the first medication in a new class to prevent chronic migraine in adults. Aimovig™ (erenumab-aooe) will be marketed by Amgen Inc. as a self-administered, once monthly, subcutaneous (under the skin) injection.

  • South Carolina limits initial opioid prescriptions

    | May 18, 2018
    Tag Icon
    Workers' Compensation, Pain Management, Formularies, Opioids
    The new law, signed May 15, 2018, limits initial opioid prescriptions for acute or postoperative pain management to a seven-day supply, with exceptions.

  • FDA approves first non-opioid medication for opioid withdrawal symptoms

    | May 17, 2018
    Tag Icon
    Workers' Compensation, Opioids
    the FDA approved Lucemyra™ (lofexidine hydrochloride) for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.